Yahoo
    NasdaqCM - Delayed Quote USD

    SeaStar Medical Holding Corporation (ICUCW)

    0.0109 -0.0058 (-34.73%)
    At close: October 30 at 10:45:18 AM EDT
    Loading Chart for ICUCW
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    ICU: QUELIMMUNE® Demonstrates Statistically Significant Survival Benefit in SAVE Registry Patients

    ICU: QUELIMMUNE® Demonstrates Statistically Significant Survival Benefit in SAVE Registry Patients
    Zacks Small Cap Research 9d ago
    SeaStar Medical Reports Statistically Significant Survival Findings from Post-Approval QUELIMMUNE® SAVE Registry Analysis in Pediatric Sepsis-Associated AKI

    SeaStar Medical Reports Statistically Significant Survival Findings from Post-Approval QUELIMMUNE® SAVE Registry Analysis in Pediatric Sepsis-Associated AKI
    GlobeNewswire 9d ago
    SeaStar Medical Chief Medical Officer Kevin Chung, MD, Named 2026 Recipient of the Combat Nephrology Award

    SeaStar Medical Chief Medical Officer Kevin Chung, MD, Named 2026 Recipient of the Combat Nephrology Award
    GlobeNewswire 17d ago
    FDA Grants SeaStar Medical Breakthrough Device Designation for its SCD Therapy for the Treatment of Hyperinflammation in Adult Patients with Sepsis or a Septic Condition

    FDA Grants SeaStar Medical Breakthrough Device Designation for its SCD Therapy for the Treatment of Hyperinflammation in Adult Patients with Sepsis or a Septic Condition
    GlobeNewswire 25d ago
    SeaStar Medical Announces Exercise of Warrants for Approximately $3.3 Million Gross Proceeds

    SeaStar Medical Announces Exercise of Warrants for Approximately $3.3 Million Gross Proceeds
    GlobeNewswire 27d ago
    SeaStar Medical Announces Late-Breaking Presentation at ASN Kidney Week 2026

    SeaStar Medical Announces Late-Breaking Presentation at ASN Kidney Week 2026
    GlobeNewswire 29d ago
    New ICD-10-PCS Codes are Now Available for the Use of SeaStar Medical’s SCD Therapy for Acute Kidney Injury (AKI)

    New ICD-10-PCS Codes are Now Available for the Use of SeaStar Medical’s SCD Therapy for Acute Kidney Injury (AKI)
    GlobeNewswire 1mo ago
    SeaStar Medical Announces Chief Medical Officer, Kevin Chung, M.D., to Present at the Pediatric Paracorporeal and Extracorporeal Therapy Symposium (PPETS) 2026

    SeaStar Medical Announces Chief Medical Officer, Kevin Chung, M.D., to Present at the Pediatric Paracorporeal and Extracorporeal Therapy Symposium (PPETS) 2026
    GlobeNewswire 1mo ago
    SeaStar Medical Congratulates H. David Humes, M.D., on Receiving the University of Michigan 2026 Distinguished University Innovator of the Year for Development of the SCD Therapy

    SeaStar Medical Congratulates H. David Humes, M.D., on Receiving the University of Michigan 2026 Distinguished University Innovator of the Year for Development of the SCD Therapy
    GlobeNewswire 1mo ago
    SeaStar Medical to Present at the HC Wainwright 28th Annual Global Investment Conference

    SeaStar Medical to Present at the HC Wainwright 28th Annual Global Investment Conference
    GlobeNewswire 1mo ago
    ICU: Continued Revenue Growth for QUELIMMUNE®

    ICU: Continued Revenue Growth for QUELIMMUNE®
    Zacks Small Cap Research 2mo ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: